Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionG protein-coupled receptor activity

OR5T1 OR5T3 NPBWR2 OR2AK2 OR5AK2 GPR33 OR5T2 GPR87 VN1R17P BDKRB1 PTH2R CELSR1 OR52A5 OR52H1 TAS1R2 TACR3 TAS2R43 OR52A1

1.91e-0588413118GO:0004930
GeneOntologyMolecularFunctionvoltage-gated calcium channel activity involved in AV node cell action potential

CACNA1C CACNA1G

1.28e-0431312GO:0086056
GeneOntologyMolecularFunctionPyrin domain binding

NLRP7 NLRP2

1.28e-0431312GO:0032090
GeneOntologyMolecularFunctiontransmembrane signaling receptor activity

IL12RB2 OR5T1 OR5T3 NPBWR2 OR2AK2 OR5AK2 GPR33 OR5T2 GPR87 VN1R17P TLR6 BDKRB1 PTH2R CELSR1 OR52A5 OR52H1 TLR3 TAS1R2 TACR3 TAS2R43 OR52A1

1.91e-04135313121GO:0004888
GeneOntologyMolecularFunctionvoltage-gated calcium channel activity involved in cardiac muscle cell action potential

CACNA1C CACNA1G

4.22e-0451312GO:0086007
GeneOntologyBiologicalProcessG protein-coupled receptor signaling pathway

OR5T1 RASGRP4 OR5T3 NPBWR2 OR2AK2 OR5AK2 GPR33 OR5T2 GPR87 VN1R17P ACE BDKRB1 PTH2R CELSR1 OR52A5 OR52H1 AGT PRKACA PRKACB TAS1R2 TACR3 TAS2R43 OR52A1

1.29e-05139512723GO:0007186
DomainLRRCT

TLR6 LRIG2 LGI3 TLR3

6.13e-05321264PF01463
DomainVPS13

VPS13C VPS13A

1.35e-0431262IPR026847
DomainVPS13_mid_rpt

VPS13C VPS13A

1.35e-0431262PF16910
DomainVPS13

VPS13C VPS13A

1.35e-0431262PF16908
DomainVPS13_N2

VPS13C VPS13A

1.35e-0431262IPR031646
DomainVPS13_mid_rpt

VPS13C VPS13A

1.35e-0431262IPR031642
DomainSHR-BD

VPS13C VPS13A

2.69e-0441262IPR009543
DomainVPS13_C

VPS13C VPS13A

2.69e-0441262PF16909
DomainVPS13_C

VPS13C VPS13A

2.69e-0441262IPR031645
DomainSHR-BD

VPS13C VPS13A

2.69e-0441262PF06650
DomainPP2A_B56

PPP2R5A PPP2R5E

4.46e-0451262IPR002554
DomainAutophagy-rel_C

VPS13C VPS13A

4.46e-0451262IPR015412
DomainB56

PPP2R5A PPP2R5E

4.46e-0451262PF01603
DomainATG_C

VPS13C VPS13A

4.46e-0451262PF09333
DomainNACHT

NLRP7 NLRP2 NOD1

4.81e-04231263PS50837
DomainNACHT_NTPase

NLRP7 NLRP2 NOD1

4.81e-04231263IPR007111
DomainGPCR_Rhodpsn_7TM

OR5T1 OR5T3 NPBWR2 OR2AK2 OR5AK2 GPR33 OR5T2 GPR87 BDKRB1 OR52A5 OR52H1 TACR3 OR52A1

6.01e-0467012613IPR017452
Domain7tm_1

OR5T1 OR5T3 NPBWR2 OR2AK2 OR5AK2 GPR33 OR5T2 GPR87 BDKRB1 OR52A5 OR52H1 TACR3 OR52A1

6.62e-0467712613PF00001
DomainG_PROTEIN_RECEP_F1_1

OR5T1 OR5T3 NPBWR2 OR2AK2 OR5AK2 GPR33 OR5T2 GPR87 BDKRB1 OR52A5 OR52H1 TACR3 OR52A1

7.37e-0468512613PS00237
DomainG_PROTEIN_RECEP_F1_2

OR5T1 OR5T3 NPBWR2 OR2AK2 OR5AK2 GPR33 OR5T2 GPR87 BDKRB1 OR52A5 OR52H1 TACR3 OR52A1

7.99e-0469112613PS50262
DomainGPCR_Rhodpsn

OR5T1 OR5T3 NPBWR2 OR2AK2 OR5AK2 GPR33 OR5T2 GPR87 BDKRB1 OR52A5 OR52H1 TACR3 OR52A1

8.10e-0469212613IPR000276
DomainPeptidase_M13_C

PHEX MMEL1

9.27e-0471262IPR018497
DomainPeptidase_M13

PHEX MMEL1

9.27e-0471262IPR000718
DomainPeptidase_M13_N

PHEX MMEL1

9.27e-0471262PF05649
DomainPeptidase_M13_N

PHEX MMEL1

9.27e-0471262IPR008753
DomainPeptidase_M13

PHEX MMEL1

9.27e-0471262PF01431
DomainChorein_N

VPS13C VPS13A

1.23e-0381262PF12624
DomainDHC_N1

DYNC1H1 DNAH11

1.23e-0381262PF08385
DomainVPS13_N

VPS13C VPS13A

1.23e-0381262IPR026854
DomainDynein_heavy_dom-1

DYNC1H1 DNAH11

1.23e-0381262IPR013594
PathwayWP_GPCRS_ODORANT

OR5T1 GPR33 OR5T2 GPR87 VN1R17P GPR108 TAS1R2 TAS2R43

1.33e-05157988MM15872
Pubmed

A synergistic association of ACE I/D and eNOS G894T gene variants with the progression of immunoglobulin A nephropathy - a pilot study.

ACE BDKRB1 AGT

5.56e-075134319546528
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

FNIP2 RAPGEF5 FSTL5 CSMD3 PPP2R5E MTMR3 SNX27 DYNC1H1 XPO7 LARGE1

4.34e-064071341012693553
Pubmed

The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease.

ACE BDKRB1 AGT

9.02e-0611134319082699
Pubmed

Effect of race, genetic population structure, and genetic models in two-locus association studies: clustering of functional renin-angiotensin system gene variants in hypertension association studies.

ACE AGT

1.47e-052134211668351
Pubmed

Understanding hypertension through genetic manipulation in mice.

ACE AGT

1.47e-052134210720939
Pubmed

AGT and ACE genes influence classic mitral valve prolapse predisposition in Marfan patients.

ACE AGT

1.47e-052134217379330
Pubmed

Angiotensinogen and angiotensin converting enzyme gene polymorphisms and the risk of bipolar affective disorder in humans.

ACE AGT

1.47e-052134211027844
Pubmed

NLRP2 controls age-associated maternal fertility.

NLRP7 NLRP2

1.47e-052134227881734
Pubmed

Role of ACE and AGT gene polymorphisms in genetic susceptibility to diabetes mellitus type 2 in a Brazilian sample.

ACE AGT

1.47e-052134226782563
Pubmed

Sex-specific effects of AGT-6 and ACE I/D on pulse pressure after 6 months on antihypertensive treatment: the GenHAT study.

ACE AGT

1.47e-052134217608790
Pubmed

[Association of polymorphisms in the angiotensin system genes with obstructive sleep apnea-hypopnea syndrome].

ACE AGT

1.47e-052134215387996
Pubmed

Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase.

PRKACA PRKACB

1.47e-05213423023318
Pubmed

Lack of association between renin-angiotensin system (RAS) polymorphisms and hypertension in Tunisian type 2 diabetics.

ACE AGT

1.47e-052134220415212
Pubmed

Reproductive Outcomes from Maternal Loss of Nlrp2 Are Not Improved by IVF or Embryo Transfer Consistent with Oocyte-Specific Defect.

NLRP7 NLRP2

1.47e-052134233090377
Pubmed

Relationship of the rs1799752 polymorphism of the angiotensin-converting enzyme gene and the rs699 polymorphism of the angiotensinogen gene to the process of in-stent restenosis in a population of Polish patients with stable coronary artery disease.

ACE AGT

1.47e-052134227162064
Pubmed

Genetic variants of ACE (Insertion/Deletion) and AGT (M268T) genes in patients with diabetes and nephropathy.

ACE AGT

1.47e-052134224737640
Pubmed

Renin-angiotensin system genes and exercise training-induced changes in sodium excretion in African American hypertensives.

ACE AGT

1.47e-052134216937603
Pubmed

Associations of ACE I/D, AGT M235T gene polymorphisms with pregnancy induced hypertension in Chinese population: a meta-analysis.

ACE AGT

1.47e-052134222644634
Pubmed

An olfactory receptor gene is located in the extended human beta-globin gene cluster and is expressed in erythroid cells.

OR52A5 OR52A1

1.47e-052134210512676
Pubmed

The I allele of the angiotensin converting enzyme I/D polymorphism confers protection against coronary artery disease.

ACE AGT

1.47e-052134220299978
Pubmed

Angiotensinogen polymorphisms and acquired atrial fibrillation in Chinese.

ACE AGT

1.47e-052134219932491
Pubmed

Epistatic effects of ACE I/D and AGT gene variants on left ventricular mass in hypertensive patients: the HyperGEN study.

ACE AGT

1.47e-052134221248783
Pubmed

Gender-dependent effect of ACE I/D and AGT M235T polymorphisms on the progression of urinary albumin excretion in Taiwanese with type 2 diabetes.

ACE AGT

1.47e-052134218849600
Pubmed

Angiotensin-converting enzyme insertion/deletion polymorphism and polyneuropathy in type 2 diabetes without macroalbuminuria.

ACE AGT

1.47e-052134212449516
Pubmed

Association of the angiotensinogen M235T and angiotensin-converting enzyme insertion/deletion gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy.

ACE AGT

1.47e-052134218413162
Pubmed

Case-control association study of polymorphisms in the angiotensinogen and angiotensin-converting enzyme genes and coronary artery disease and systemic artery hypertension in African-Brazilians and Caucasian-Brazilians.

ACE AGT

1.47e-052134227019433
Pubmed

Renin-angiotensin system gene polymorphisms and atrial fibrillation.

ACE AGT

1.47e-052134215023884
Pubmed

Essential arterial hypertension and polymorphism of angiotensinogen M235T gene.

ACE AGT

1.47e-052134212169209
Pubmed

Angiotensin-converting enzyme and angiotensinogen gene polymorphisms are non-randomly distributed in oral contraceptive-induced hypertension.

ACE AGT

1.47e-052134211330874
Pubmed

[Genetic polymorphisms of the renin-angiotensin system and essential hypertension].

ACE AGT

1.47e-052134212015946
Pubmed

[Gene polymorphism of the renin-angiotensin system in six ethnic/geographic regions of Belarus].

ACE AGT

1.47e-052134218672804
Pubmed

Polymorphism of the renin-angiotensin-aldosterone system in patients with chronic allograft dysfunction.

ACE AGT

1.47e-052134216635753
Pubmed

ACE and angiotensinogen gene genotypes and left ventricular mass in athletes.

ACE AGT

1.47e-052134211737220
Pubmed

Investigation of -PRKACA/-PRKACB fusion genes in oncocytic tumors of the pancreatobiliary and other systems.

PRKACA PRKACB

1.47e-052134236152045
Pubmed

PRKACA/PRKACB Fusions in Pancreatobiliary Intraductal Oncocytic Papillary Neoplasms Including Those With Atypical Morphology: An Analysis of 22 Cases Expanding Morphologic Spectrum.

PRKACA PRKACB

1.47e-052134238841868
Pubmed

Polymorphisms of angiotensinogen and angiotensin-converting enzyme associated with lower extremity arterial disease in the Health, Aging and Body Composition study.

ACE AGT

1.47e-052134217429448
Pubmed

Association of the ACE and AGT gene polymorphisms with global disparities in COVID-19-related deaths.

ACE AGT

1.47e-052134236853865
Pubmed

Association between ACE and AGT polymorphism and cardiovascular risk in acromegalic patients.

ACE AGT

1.47e-052134228712073
Pubmed

The role of Toll-like receptor polymorphisms in acute pancreatitis occurrence and severity.

TLR6 TLR3

1.47e-052134225423559
Pubmed

Genetic polymorphisms of angiotensin-I converting enzyme, haptoglobin and angiotensinogen and oxidative stress parameters in 12 to 15-year-old adolescents.

ACE AGT

1.47e-052134217069434
Pubmed

The relationship between ACE/AGT gene polymorphisms and the risk of diabetic retinopathy in Chinese patients with type 2 diabetes.

ACE AGT

1.47e-052134229378484
Pubmed

Renin angiotensin system gene polymorphisms modify angiotensin-converting enzyme inhibitors' effect on cognitive function: the health, aging and body composition study.

ACE AGT

1.47e-052134220722844
Pubmed

Association of angiotensin-converting enzyme insertion/deletion (ACE I/D) and angiotensinogen (AGT M235T) polymorphisms with the risk of obesity in a Tunisian population.

ACE AGT

1.47e-052134232356512
Pubmed

Angiotensinogen 235T allele "dosage" is associated with blood pressure phenotypes.

ACE AGT

1.47e-052134212511525
Pubmed

Impact of maternal angiotensinogen M235T polymorphism and angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure, protein excretion and fetal outcome in pregnancy.

ACE AGT

1.47e-052134217563539
Pubmed

Molecular and behavioral effects of a null mutation in all PKA C beta isoforms.

PRKACA PRKACB

1.47e-052134212139926
Pubmed

Suppressing NLRP2 expression accelerates hepatic steatosis: A mechanism involving inflammation and oxidative stress.

NLRP7 NLRP2

1.47e-052134230454891
Pubmed

The influence of Angiotensin converting enzyme and angiotensinogen gene polymorphisms on hypertrophic cardiomyopathy.

ACE AGT

1.47e-052134224204726
Pubmed

[Polymorphisms of genes of rennin-angiotensine system and their correlation with psychological manifestations of birth stress].

ACE AGT

1.47e-052134219062524
Pubmed

Association of Angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia.

ACE AGT

1.47e-052134215082899
Pubmed

Renin-angiotensin system gene polymorphisms predict the progression to renal insufficiency among Asians with lupus nephritis.

ACE AGT

1.47e-052134215789057
Pubmed

NLRP2 inflammasome in dorsal root ganglion as a novel molecular platform that produces inflammatory pain hypersensitivity.

NLRP7 NLRP2

1.47e-052134231162334
Pubmed

ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS.

ACE AGT

1.47e-052134217107992
Pubmed

Relation of renin-angiotensin system gene polymorphisms and expressions with the efficacy of antihypertensive drugs.

ACE AGT

1.47e-052134212426159
Pubmed

Epistatic effects between two genes in the renin-angiotensin system and systolic blood pressure and coronary artery calcification.

ACE AGT

1.47e-052134216572049
Pubmed

Sex-specific effects of ACE I/D and AGT-M235T on pulse pressure: the HyperGEN Study.

ACE AGT

1.47e-052134217492314
Pubmed

Influence of angiotensinogen and angiotensin-converting enzyme polymorphisms on cardiac hypertrophy and improvement on maximal aerobic capacity caused by exercise training.

ACE AGT

1.47e-052134219404196
Pubmed

cAMP-dependent regulation of cardiac L-type Ca2+ channels requires membrane targeting of PKA and phosphorylation of channel subunits.

CACNA1C PRKACA

1.47e-05213429247274
Pubmed

Characterization of genomic clones coding for the C alpha and C beta subunits of mouse cAMP-dependent protein kinase.

PRKACA PRKACB

1.47e-05213422833513
Pubmed

Identification of a novel cAMP dependent protein kinase A phosphorylation site on the human cardiac calcium channel.

CACNA1C PRKACA

1.47e-052134229123182
Pubmed

[Polymorphism of the promotor region of the angiotensinogen gene and the gene for angiotensin I-converting enzyme in arterial hypertension and myocardial ischemia of the Kazakh ethnic groups].

ACE AGT

1.47e-052134212669427
Pubmed

Insertion/deletion polymorphism on ACE gene is associated with endothelial dysfunction in young patients with hypertension.

ACE AGT

1.47e-052134216981142
Pubmed

Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study.

ACE AGT

1.47e-052134211677359
Pubmed

Association of angiotensinogen gene M235T and angiotensin-converting enzyme gene I/D polymorphisms with essential hypertension in Han Chinese population: a meta-analysis.

ACE AGT

1.47e-052134220087216
Pubmed

Unchanged beta-adrenergic stimulation of cardiac L-type calcium channels in Ca v 1.2 phosphorylation site S1928A mutant mice.

CACNA1C PRKACA

1.47e-052134218829456
Pubmed

Renin angiotensin system gene polymorphisms and cerebral blood flow regulation: the MOBILIZE Boston study.

ACE AGT

1.47e-052134220185782
Pubmed

NLRP2 is highly expressed in a mouse model of ischemic stroke.

NLRP7 NLRP2

1.47e-052134227693696
Pubmed

Influence of gender and genetic variability on plasma angiotensin peptides.

ACE AGT

1.47e-052134217083063
Pubmed

Gene polymorphisms of angiotensin-converting enzyme and angiotensinogen and risk of idiopathic ischemic stroke.

ACE AGT

1.47e-052134230521887
Pubmed

Global consequences of activation loop phosphorylation on protein kinase A.

PRKACA PRKACB

1.47e-052134219965870
Pubmed

Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: the PROCAGENE study. Prospective Cardiac Gene.

ACE AGT

1.47e-052134211345362
Pubmed

Lack of association of ACE/angiotensinogen genotype with renal function in autosomal dominant polycystic kidney disease.

ACE AGT

1.47e-052134211142763
Pubmed

Associations of polymorphisms of the angiotensinogen M235 polymorphism and angiotensin-converting-enzyme intron 16 insertion/deletion polymorphism with preeclampsia in Korean women.

ACE AGT

1.47e-052134215294367
Pubmed

Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study.

ACE AGT

1.47e-052134211181802
Pubmed

Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy.

ACE AGT

1.47e-052134211431175
Pubmed

Cardiovascular diseases and molecular variants of the renin-angiotensin system components in Slovak population.

ACE AGT

1.47e-052134217579251
Pubmed

Polymorphisms of the insertion / deletion ACE and M235T AGT genes and hypertension: surprising new findings and meta-analysis of data.

ACE AGT

1.47e-052134215642127
Pubmed

A genetic association study of NLRP2 and NLRP7 genes in idiopathic recurrent miscarriage.

NLRP7 NLRP2

1.47e-052134223360675
Pubmed

Protein kinase A translocation and insulin secretion in pancreatic beta-cells: studies with adenylate cyclase toxin from Bordetella pertussis.

PRKACA PRKACB

1.47e-052134212180908
Pubmed

Brain-specific transcript variants of 5' and 3' ends of mouse VPS13A and VPS13C.

VPS13C VPS13A

1.47e-052134217196930
Pubmed

Association Between M235T-AGT and I/D-ACE Polymorphisms and Carotid Atheromatosis in Hypertensive Patients: A Cross-Sectional Study.

ACE AGT

1.47e-052134232871819
Pubmed

Cyclic AMP-dependent protein kinase phosphorylates residues in the C-terminal domain of the cardiac L-type calcium channel alpha1 subunit.

CACNA1C PRKACA

1.47e-05213428664319
Pubmed

COC use, ACE/AGT gene polymorphisms, and risk of stroke.

ACE AGT

1.47e-052134220300047
Pubmed

Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and Bile Duct.

PRKACA PRKACB

1.47e-052134231678302
Pubmed

[Angiotensinogen and angiotensin-I converting enzyme gene variations in Chinese pregnancy induced hypertension].

ACE AGT

1.47e-052134212575194
Pubmed

Cardiac hypertrophy and remodeling in relation to ACE and angiotensinogen genes genotypes in Chinese dialysis patients.

ACE AGT

1.47e-052134212675870
Pubmed

Polymorphism of the angiotensin-converting enzyme (ACE) and angiotesinogen (AGT) genes and their associations with blood pressure and carotid artery intima media thickness among healthy Finnish young adults--the Cardiovascular Risk in Young Finns Study.

ACE AGT

1.47e-052134216387306
Pubmed

Renin-angiotensin system gene polymorphisms in children with Henoch-Schönlein purpura in West China.

ACE AGT

1.47e-052134220702504
Pubmed

Systems-level identification of PKA-dependent signaling in epithelial cells.

PRKACA PRKACB

1.47e-052134228973931
Pubmed

Angiotensinogen t235 and angiotensin-converting enzyme insertion/deletion polymorphisms associated with the development of posttransplantation diabetes mellitus in renal allograft recipients.

ACE AGT

1.47e-052134221440764
Pubmed

A potential site of functional modulation by protein kinase A in the cardiac Ca2+ channel alpha 1C subunit.

CACNA1C PRKACA

1.47e-05213428612821
Pubmed

The Severity of Oxidative Stress in Comorbid Chronic Obstructive Pulmonary Disease (COPD) and Hypertension: Does it Depend On ACE and AGT Gene Polymorphisms?

ACE AGT

1.47e-052134232025262
Pubmed

Association of AGT M235T and ACE I/D polymorphisms with the risk of ischemic stroke: meta-analysis in Han Chinese population.

ACE AGT

1.47e-052134222800767
Pubmed

Diabetic Nephropathy Induced by Increased Ace Gene Dosage Is Associated with High Renal Levels of Angiotensin (1-7) and Bradykinin.

ACE AGT

1.47e-052134226442284
Pubmed

Association between polymorphisms of the angiotensin-converting enzyme and angiotensinogen genes and allergic rhinitis in a Korean population.

ACE AGT

1.47e-052134215112973
Pubmed

Nlrp2, a maternal effect gene required for early embryonic development in the mouse.

NLRP7 NLRP2

1.47e-052134222295082
Pubmed

Gene Rearrangement and Expression of PRKACA and PRKACB Govern Morphobiology of Pancreatobiliary Oncocytic Neoplasms.

PRKACA PRKACB

1.47e-052134237871652
Pubmed

[The role of polymorphic variants of renin-angiotensin system genes in the development of ischemic stroke in Moscow population].

ACE AGT

1.47e-052134212830507
Pubmed

Major role for ACE-independent intrarenal ANG II formation in type II diabetes.

ACE AGT

1.47e-052134219846569
Pubmed

Association of the genetic polymorphisms of the renin-angiotensin system with kidney graft long-term outcome: preliminary results.

ACE AGT

1.47e-052134216386515
Cytoband11p15.5

ANO9 PGGHG MOB2 PGAP2 OR52A1

2.64e-05118134511p15.5
CytobandEnsembl 112 genes in cytogenetic band chr11p15

ANO9 PGGHG TRIM22 MOB2 OR52A5 PGAP2 OR52H1 OR52A1

2.66e-045641348chr11p15
Cytoband20q12-q13.1

RPN2 PLCG1

3.75e-0410134220q12-q13.1
GeneFamilyNLR family

NLRP7 NLRP2 NOD1

2.88e-0425943666
GeneFamilyCD molecules|Toll like receptors

TLR6 TLR3

1.17e-0310942948
GeneFamilyOlfactory receptors, family 52

OR52A5 OR52H1 OR52A1

2.11e-0349943165
GeneFamilyWD repeat domain containing|Protein phosphatase 2 regulatory subunits

PPP2R5A PPP2R5E

2.69e-0315942696
GeneFamilyOlfactory receptors, family 5

OR5T1 OR5T3 OR5AK2 OR5T2

2.77e-03112944152
ToppCellLPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

RAPGEF5 CD109 ACE TRIM22 MOB2 FRY PPP2R5A SLC12A2

1.61e-072001338b7533c571eeea0cb3678e1a57d3dc036fa8d0f49
ToppCellnormal-na-Lymphocytic_B-B_plasma-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

DENND5B NLRP7 ITGA8 PKHD1L1 PHEX CELSR1 LARGE1

8.10e-071701337c5b87974dfddf9780051f7f5693eeeb0c606a3fe
ToppCellControl-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class

FNIP2 TRPM2 TLR6 ITGAD ABCA9 STAB1 CELSR1

9.47e-0717413374c64ff5666812fb4efa440ba4faeca51d916d68e
ToppCellfacs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TSC22D3 RAPGEF5 ABCA9 STAB1 ARHGAP5 MID1 TLR3

1.89e-06193133706b65110db974f4ef90d3511ff34428976a52c9c
ToppCellfacs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TSC22D3 RAPGEF5 ABCA9 STAB1 ARHGAP5 MID1 TLR3

1.89e-061931337a4f91bca5eaa985982d33a528f7566ffde154d47
ToppCellfacs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TSC22D3 RAPGEF5 ABCA9 STAB1 ARHGAP5 MID1 TLR3

1.89e-061931337b39d7feaac4ff8f7409cd3d15e8f3c6391367275
ToppCellCOVID-19_Mild|World / Disease group, lineage and cell class

TSC22D3 VPS13C CHD1 TRIM22 STAT2 DDX60L FMNL1

2.17e-0619713375c33454b10023decd2f5ccda9229b6512659711e
ToppCellControl_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type

RAPGEF5 ST3GAL1 ACE TRIM22 MOB2 PPP2R5A SLC12A2

2.39e-062001337041a34080120c9f613373c20dcc366292f558040
ToppCellLPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

RAPGEF5 ACE TRIM22 FRY PPP2R5A SLC12A2 DYNC1H1

2.39e-06200133779e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCellLPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

RAPGEF5 CD109 ACE TRIM22 MOB2 PPP2R5A SLC12A2

2.39e-062001337a1fa6bae5a688faf488d6925cd3fad725dfa916b
ToppCellLPS_anti-TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

RAPGEF5 ACE TRIM22 MOB2 FRY PPP2R5A SLC12A2

2.39e-06200133789a6da2bdedc6b1ad0675c8753bf2b763a99af6a
ToppCellLPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

RAPGEF5 CD109 ACE TRIM22 MOB2 PPP2R5A SLC12A2

2.39e-0620013371d105eeda5a2c51f9a4654ffc79b7e2348ad593b
ToppCellLPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

RAPGEF5 ST3GAL1 ACE TRIM22 MOB2 PPP2R5A SLC12A2

2.39e-06200133758a7ece7dfdf6c46f2a50cbcb580574dec14c748
ToppCellLPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

RAPGEF5 CD109 ACE TRIM22 MOB2 PPP2R5A SLC12A2

2.39e-062001337d01cec331be3b03cef80e9536fc531285bcf00f6
ToppCellControl_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type

RAPGEF5 CD109 ACE TRIM22 PPP2R5A SLC12A2 DYNC1H1

2.39e-062001337be55cef682ba87250dad97689332c8820b3a7420
ToppCellLPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

RAPGEF5 CD109 ACE TRIM22 MOB2 PPP2R5A SLC12A2

2.39e-06200133760d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af
ToppCell367C-Epithelial_cells-Epithelial-D_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

ELAPOR2 ITGA8 NBPF26 CD1E LGI3 AGT

4.21e-061411336f3b1d757c4cac8596c542959c8f27f8bcaf3f513
ToppCell367C-Epithelial_cells-Epithelial-D_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

ELAPOR2 ITGA8 NBPF26 CD1E LGI3 AGT

4.21e-061411336bf68a54e755cda89fbc416636e522cd71d1e42d0
ToppCellfacs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CACNA1C ELAPOR2 VPS13C ITGAD SLC9A7 FITM2

1.40e-051741336f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCellControl-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class

TRPM2 TLR6 ITGAD ABCA9 STAB1 CELSR1

1.54e-051771336470f54fe2b21c7350ea471e02039461a3808f700
ToppCelldroplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SEMA3F NLRP2 PKHD1L1 STAB1 CELSR1 IPO11

1.75e-051811336cef034030e6b029a49ae56be37ea1fac1a5c350e
ToppCellRA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper

CACNA1C NBEAL1 RAPGEF5 ITGA8 FRY MID1

1.86e-051831336cae2ee08f985a6f005b4b8e959e465350315156a
ToppCellCV-Healthy-7|Healthy / Virus stimulation, Condition and Cluster

ZWILCH HAUS6 OSTM1 IGHMBP2 TLR3 PRKACA

1.98e-0518513361979d189c204f4c2893e3170a514ee7d5523406c
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RAPGEF5 CD109 ACE TRIM22 PPP2R5A SLC12A2

2.17e-05188133673f6ec915934154f435a376cb274b058ff7c5f35
ToppCellLA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper

CACNA1C NBEAL1 RAPGEF5 ITGA8 FRY MID1

2.17e-05188133634e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCellCerebellum-Macroglia-ASTROCYTE-Gja1-Gfap+_astrocytes_(Gfap)--|Cerebellum / BrainAtlas - Mouse McCarroll V32

ERV3-1 CD109 GPAM CELSR1 IGSF1

2.27e-051131335fed408864201218295bac0cc6647953fda8d688e
ToppCellCerebellum-Macroglia-ASTROCYTE-Gja1-Gfap+_astrocytes_(Gfap)-|Cerebellum / BrainAtlas - Mouse McCarroll V32

ERV3-1 CD109 GPAM CELSR1 IGSF1

2.27e-051131335c0b8d7a2e3722029e850051bdff77f31f34a8cca
ToppCellCerebellum-Macroglia-ASTROCYTE-Gja1-Gfap+_astrocytes_(Gfap)|Cerebellum / BrainAtlas - Mouse McCarroll V32

ERV3-1 CD109 GPAM CELSR1 IGSF1

2.27e-0511313357e24c0f6a80e10a2a41325d48a87628bd330a1e2
ToppCellLPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RAPGEF5 CD109 ACE TRIM22 PPP2R5A SLC12A2

2.30e-051901336474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCellhuman_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells)

FNIP2 TRPM2 CD109 MCOLN1 DDX60L FMNL1

2.37e-0519113363b59bfc6c106ae8a3fbcd4a74bd128c485724921
ToppCellfacs-Heart-LA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DENND5B PKHD1L1 STAB1 FRY CELSR1 IPO11

2.44e-05192133614a816ef116aa992f86edab411f043cf7d07fe04
ToppCellLPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RAPGEF5 CD109 ACE TRIM22 PPP2R5A SLC12A2

2.44e-05192133604f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RAPGEF5 CD109 ACE TRIM22 PPP2R5A SLC12A2

2.44e-051921336c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCellPCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

ANO9 RAPGEF5 FSTL5 FRY CELSR1 RASSF6

2.44e-051921336b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCellfacs-Heart-LA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DENND5B PKHD1L1 STAB1 FRY CELSR1 IPO11

2.44e-051921336847822514d747a21d5eb40e04ba9a023fd32bd65
ToppCellfacs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RAPGEF5 ABCA9 STAB1 ARHGAP5 MID1 TLR3

2.52e-0519313369c16032bc03df8760ae199e8f19fdafa4c3f1827
ToppCellLPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RAPGEF5 CD109 ACE TRIM22 PPP2R5A SLC12A2

2.52e-05193133602f633b016ab19bfa65bfd0cf32f000549a62148
ToppCellLPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RAPGEF5 CD109 ACE TRIM22 PPP2R5A SLC12A2

2.52e-0519313365122b1ffba42de190061be34ecdc6176f84e56a3
ToppCellfacs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SEMA3F RAPGEF5 ACE STAB1 PPP2R5A PLCG1

2.67e-0519513367f9b7f15006610ad591063d90e90367bd6083c7f
ToppCellSepsis-ICU-NoSEP-Lymphocyte-B-Plasmablast|ICU-NoSEP / Disease, condition lineage and cell class

DENND5B IL12RB2 RAPGEF5 PKHD1L1 PTH2R PGAP2

2.82e-0519713368f35f9741086a38f0e594dce0547b575946f52bb
ToppCellCOVID-19_Mild|World / Disease condition and Cell class

CHD1 TRIM22 STAT2 DDX60L FMNL1 DYNC1H1

2.90e-05198133661ceb2245b6cb58e308b999a61d218c89dbc615e
ToppCellPBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)

VPS13C CHD1 TRIM22 STAT2 DDX60L FMNL1

2.90e-05198133644417089b62056269cac38d3134ff209c05b7007
ToppCellPBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

VPS13C CHD1 TRIM22 STAT2 DDX60L FMNL1

2.90e-05198133628ef3fc4c17dcb765537b75917f7db78baa522db
ToppCellLPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

RAPGEF5 ACE TRIM22 PPP2R5A SLC12A2 DYNC1H1

3.07e-05200133672ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCellLPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

RAPGEF5 ACE TRIM22 FRY PPP2R5A SLC12A2

3.07e-052001336bcd1cc96197929d6011903803b6f4ccdcf52b4ce
ToppCellLPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

RAPGEF5 ACE TRIM22 PPP2R5A SLC12A2 DYNC1H1

3.07e-0520013365c092b2ecc081b5d04476c56333c338cd89ab984
ToppCellLPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

RAPGEF5 ACE TRIM22 SLC12A2 DDX60L DYNC1H1

3.07e-05200133689821a264e872ed53e08e9d3609d5cc5c314503e
ToppCellLPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / Treatment groups by lineage, cell group, cell type

RAPGEF5 ACE TRIM22 MOB2 PPP2R5A SLC12A2

3.07e-052001336b1fadb2b5e37e0f51e079d8409c2647eef68dc3b
ToppCellControl_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type

RAPGEF5 CD109 ACE TRIM22 PPP2R5A SLC12A2

3.07e-052001336e77eba6172cabf85b8028638ed35299f2f079cd8
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

VPS13C CHD1 TRIM22 STAT2 DDX60L DYNC1H1

3.07e-05200133612f1685ce8f218433068e090c9d839cd5a1910bf
ToppCellLPS_anti-TNF-Endothelial-Endothelial-Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

RAPGEF5 ACE MOB2 FRY PPP2R5A SLC12A2

3.07e-05200133666f7e8ee63c828f17468e79a4b816346b33e8980
ToppCellLPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

RAPGEF5 ACE MOB2 FRY PPP2R5A SLC12A2

3.07e-052001336b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c
ToppCellControl_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type

RAPGEF5 CD109 ACE TRIM22 FRY SLC12A2

3.07e-052001336abf4ba5fcb54cdeada0da1a8b956a30aa47679e4
ToppCellLPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type

RAPGEF5 ACE TRIM22 FRY PPP2R5A SLC12A2

3.07e-052001336432384faeade8e609154fab3d96c955a8ec868dd
ToppCellControl_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type

RAPGEF5 CD109 ACE TRIM22 PPP2R5A SLC12A2

3.07e-0520013363372c488a39fe812fa94e4f0564594186fea3db5
ToppCellCOVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class

TSC22D3 VPS13C CHD1 TRIM22 STAT2 FMNL1

3.07e-05200133662c25042086f1afd1102e0720e933c2e476468fd
ToppCelldroplet-Fat-Gat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMEM229A AXIN2 GREB1L LRIG2 AGT

4.79e-0513213354152529611eeacf0c547e2a134d5b98c45426b13
ToppCellSubstantia_nigra-Macroglia-ASTROCYTE|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

ERV3-1 MIR17HG AGT TLR3 IGSF1

5.15e-051341335a632d78890fcc20db81d2cf6b299470706d2e182
ToppCellSubstantia_nigra-Macroglia-ASTROCYTE-Gja1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

ERV3-1 MIR17HG AGT TLR3 IGSF1

5.15e-0513413358be2db71d9d29f9a57a64efdc89cf8c3e32b363b
ToppCelldroplet-Pancreas-Exocrine-18m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RASGRP4 ITGA8 ABCA9 STAB1 MID1

6.78e-051421335bf4a9633d128805a0d7e426d6fe6c29db1ff8c81
ToppCelldroplet-Pancreas-Exocrine-18m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RASGRP4 ITGA8 ABCA9 STAB1 MID1

7.99e-051471335684e2d8d2f0516cf8b0dc53efa7efc3050bbf0d1
ToppCelldroplet-Pancreas-Exocrine-18m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RASGRP4 ITGA8 ABCA9 STAB1 MID1

7.99e-051471335c031fad0a4e192019775809968e46da54a111d27
ToppCell368C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

SEMA3F RAPGEF5 AXIN2 CELSR1 OR52H1

9.64e-0515313359f0607a88d5f8a2c128a2ff64dfbc986212f13b2
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ZWILCH CCDC175 PTH2R GREB1L DNAH11

9.64e-051531335d6526d17826470534b766df144c74e73eb83fdad
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FSTL5 ST3GAL1 INPP5F CSMD3 PCDH18

1.03e-041551335cba6f3f7742b4d5d54ad0a0ac0dd4016e73fe658
ToppCellChildren_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor

CACNA1C ITGA8 ABCA9 MMEL1 AGT

1.09e-041571335f147e24f2ece82e1c54750868954d09b3c461804
ToppCelldroplet-Liver-LIVER_NPC-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPR33 ACE MMEL1 OLFM1 FMNL1

1.12e-04158133590ca742739a208d457db087655ba3d1c18a9da57
ToppCellfacs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ATP8B3 PTH2R GREB1L MMEL1 CFAP57

1.12e-041581335f296ca24fdedc33f1d24b79e7660763114ce7fa3
ToppCellfacs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ATP8B3 PTH2R GREB1L MMEL1 CFAP57

1.12e-0415813358c7108f2c40d97a317762ba0b8eca76542b2ebaf
ToppCelldroplet-Liver-LIVER_HEP-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZWILCH ITGAD ACE FRY FMNL1

1.12e-04158133591d265e95156f16459924d3e4dd11c180e164eee
ToppCellChildren_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

CACNA1C ITGA8 ABCA9 MMEL1 AGT

1.12e-041581335e5636c0b608d68bd426a2b446ac508e4512e86a4
ToppCellsevere_COVID-19-pDC|severe_COVID-19 / disease group, cell group and cell class (v2)

IL12RB2 NLRP7 NLRP2 ABCA9 PHEX

1.16e-041591335ea5088d27e42b8850455764d53b757ea8d8f14bc
ToppCelldroplet-Liver-LIVER_NPC-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPR33 ACE MMEL1 OLFM1 FMNL1

1.19e-0416013358dae9b0cf90a09acb196223f45a14680102630b2
ToppCellfacs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PAQR9 ITGA8 PKHD1L1 PHEX CACNA1G

1.19e-04160133556e6f4b82b5dc41c45f9d253c2db314a6f702b84
ToppCellfacs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PAQR9 ITGA8 PKHD1L1 PHEX CACNA1G

1.19e-041601335bb1b966fb9e801db15e67d03e49db4609d6f935a
ToppCellPND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PKHD1L1 STAB1 CELSR1 OLFM1 IPO11

1.23e-041611335133b4fadb499e842c19f573f9cf09ce08c1d4813
ToppCellPND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PKHD1L1 STAB1 CELSR1 OLFM1 IPO11

1.23e-0416113359466b8658244116f8d21f2f88fb8c2d184b1bdf2
ToppCellICU-NoSEP-Lymphocyte-B-Plasmablast|ICU-NoSEP / Disease, Lineage and Cell Type

DENND5B RAPGEF5 ITGA8 PKHD1L1 PTH2R

1.23e-0416113358ca34d800551cb0f796293e6bfdcbf58509cc668
ToppCelldroplet-Thymus-nan-21m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PAQR9 TRPM2 ITGA8 TLR3 OLFM1

1.23e-041611335441ebd3c029861d833fbcf8a68fc740d9de8ef2f
ToppCellPND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PKHD1L1 STAB1 CELSR1 OLFM1 IPO11

1.23e-041611335cb177ca10d848d0e25399ab5ebfcde1071fb94c2
ToppCellfacs-Marrow-Granulocytes-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PAQR9 ITGA8 PKHD1L1 PHEX CACNA1G

1.23e-04161133560f433eab9d5531bdf6aa86b0265f20b866b904c
ToppCellfacs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CACNA1C ELAPOR2 CSMD3 PKHD1L1 TACR3

1.26e-041621335bf886e22ff2a20353499004b53f25fb9e6574896
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

DENND5B NLRP7 RAPGEF5 PKHD1L1 SLC16A14

1.26e-0416213358278dccdb139396ede34b83b02ebce837f2489d6
ToppCellPND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PKHD1L1 STAB1 CELSR1 OLFM1 IPO11

1.26e-04162133596c6e94a10b124a1d25dcd705ec5aaa8609c1089
ToppCellPND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CD109 FSD2 PKHD1L1 STAB1 IPO11

1.37e-04165133550a8513d8d2630861499393a7f102b35366bad37
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells-neuroepithelial-like_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.

FSTL5 MMEL1 CFAP221 SLC9A7 PGBD3

1.45e-041671335e488d9c7cf4355959e3833de3bd496c13fc11b1b
ToppCell390C-Lymphocytic-ILC-ILC-2|390C / Donor, Lineage, Cell class and subclass (all cells)

IL12RB2 TSC22D3 NLRP2 PRKACB PLCG1

1.49e-0416813352781dd6b369427a94c5059b44b4c8f023f5f2988
ToppCelldroplet-Liver-Npc-18m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RASGRP4 CFAP221 TLR3 OLFM1 FMNL1

1.49e-041681335ce5e92a1df3acfa5cd8d5a134e4af231dc592a13
ToppCellfacs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DENND5B PKHD1L1 STAB1 GREB1L IPO11

1.49e-04168133506dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46
ToppCell367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)

SCAMP1 DDIAS CELSR1 MMEL1 AGT

1.49e-0416813352fb2d916eb5000a637240d38e47a9b4f61f9f83f
ToppCelldroplet-Liver-Npc-18m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RASGRP4 CFAP221 TLR3 OLFM1 FMNL1

1.49e-04168133522c89d4eb44573f6301069ec7ca7cbd0dd958403
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VPS13C TBC1D8B PGAP2 PRKACB DNAH11

1.49e-041681335d69452e2cfeb74023b5cf3d09064d7dcad0008ec
ToppCellASK440-Immune-B_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq

NLRP2 RASSF6 FITM2 IPO11 LARGE1

1.49e-041681335127559d1a083c68cda9fce143afcc3eec168df17
ToppCellfacs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DENND5B PKHD1L1 STAB1 GREB1L IPO11

1.49e-0416813351002f058a340763e3d8de0bd1f0547a903526ec6
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-NK-NK-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ANO9 TSC22D3 NBEAL1 ITGAD NLRP2

1.58e-041701335aaf29c2d4de172d366cbfc863bc741941667dde1
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9

CD109 MMEL1 CFAP221 TLR3 CFAP57

1.62e-04171133574be8d3bf6b99e2d734635a8b1a7c41e8c596959
ToppCellCD8+_Memory_T_cell-FLU-3|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster

ATP8B3 NBPF20 AXIN2 LINS1 CENPI

1.67e-04172133545ac433dbb3796f69e886c04457b2971403050ee
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FSTL5 ST3GAL1 INPP5F CSMD3 PCDH18

1.67e-0417213357e1a7700a4c2b1d100da1d6e475e73498ebb605a
ToppCellFLU-Healthy-3|FLU / Virus stimulation, Condition and Cluster

ATP8B3 NBPF20 AXIN2 LINS1 CENPI

1.71e-04173133532b8e5b400885dbeba57a7cb2c18d882664dc285
ToppCellFLU-Healthy-3|Healthy / Virus stimulation, Condition and Cluster

ATP8B3 NBPF20 AXIN2 LINS1 CENPI

1.71e-04173133526e89ac86922f1cd0100cf4d1cce37e74dd31c88
DrugSch 39370

ACE BDKRB1 MMEL1 AGT TACR3

4.42e-07271325CID000121872
DrugMK-996

ACE BDKRB1 AGT

1.04e-0581323CID000133031
Drugzabiciprilat

ACE BDKRB1 AGT

1.04e-0581323CID000065680
DrugNeurotensin (1-10)

ACE MMEL1 AGT

1.04e-0581323CID003085266
Drugzofenoprilat

ACE BDKRB1 MMEL1 AGT

1.46e-05261324CID003034048
Drugangiotensin I

ACE BDKRB1 AGT

1.56e-0591323CID000447320
DrugFK-506; Up 200; 1uM; MCF7; HG-U133A

SEMA3F MCOLN1 SBNO2 NOD1 RALBP1 NUP210 CENPI PLCG1

2.01e-051971328284_UP
DrugDantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A

RAPGEF5 TRPM2 TRIM22 BDKRB1 PTH2R PCNX2 PPP2R5A SLC9A7

2.01e-0519713283978_UP
DrugLeucomisine [17946-87-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A

PGGHG ITGA8 CD1E NOD1 AGT MID1 SLC9A7 OLFM1

2.16e-0519913286767_UP
DrugLys-Bradykinin

ACE BDKRB1 PHEX MMEL1 AGT

2.57e-05601325CID000009569
DrugAC1L1KS5

CACNA1C NPBWR2 GPR87 BDKRB1 AGT PRKACA PRKACB CACNA1G TACR3 PLCG1

2.59e-0533413210CID000005631
DrugAC1L1MRO

ACE BDKRB1 AGT

3.04e-05111323CID000057327
DrugMDL 100240

ACE BDKRB1 AGT

3.04e-05111323CID000133985
DrugRb 104

ACE MMEL1 AGT

3.04e-05111323CID000132708
Druglercanidipine

CACNA1C ACE BDKRB1 AGT CACNA1G

3.26e-05631325CID000065866
DrugPhenacein

ACE AGT

3.34e-0521322CID000125262
Druggoralatide

ACE BDKRB1

3.34e-0521322ctd:C058504
DrugmM OPA

ACE AGT

3.34e-0521322CID000133560
Drugo-aminohippuric acid

ACE AGT

3.34e-0521322CID003080562
Drugecadotril

ACE MCOLN1 MMEL1 AGT

3.88e-05331324CID000060561
Drugalatriopril

ACE MMEL1 AGT

4.03e-05121323CID000131850
Drugsampatrilat

ACE MMEL1 AGT

5.22e-05131323CID006324648
DrugYS980

ACE MMEL1 AGT

5.22e-05131323CID000171857
DrugSCH 42495

ACE MMEL1 AGT

6.62e-05141323CID000131965
Drugfosinoprilat

ACE BDKRB1 AGT

6.62e-05141323CID000062956
Drugmergetpa

ACE BDKRB1 MMEL1 AGT

9.26e-05411324CID000123726
DrugT-kinin

ACE BDKRB1 PHEX AGT

9.26e-05411324CID000123643
DrugNSC-694280

ACE BDKRB1 PHEX MMEL1 AGT TACR3

9.87e-051271326CID000004802
DrugCGS 13934

ACE AGT

9.97e-0531322CID000134126
DrugMC-838

ACE AGT

9.97e-0531322CID005488868
DrugL-681,176

ACE AGT

9.97e-0531322CID000124628
DrugWf 10129

ACE AGT

9.97e-0531322CID003080984
DrugMDL 27,088

ACE AGT

9.97e-0531322CID005489408
DrugD03743

ACE AGT

9.97e-0531322CID000064922
DrugRev 5975

ACE AGT

9.97e-0531322CID000127983
DrugRADHP

ACE BDKRB1

9.97e-0531322CID000152929
Drugtert-butyl L-alaninate

ACE AGT

9.97e-0531322CID000089016
Drugimidaprilat

ACE AGT

9.97e-0531322ctd:C078006
DrugAC1MJ2VJ

ACE AGT

9.97e-0531322CID003084602
DrugBpgp

ACE AGT

9.97e-0531322CID000130842
DrugC112 Peptide

ACE AGT

9.97e-0531322CID000181457
DrugC111 Peptide

ACE AGT

9.97e-0531322CID000181456
DrugBl 11

ACE AGT

9.97e-0531322CID003033886
Drug3-aminoquinoline

MID1 TACR3

9.97e-0531322CID000011375
DrugGR117289

ACE AGT

9.97e-0531322CID000072168
DrugGaI3

ACE AGT

9.97e-0531322CID000083478
DrugAC1MUFT5

ACE MMEL1 AGT

1.01e-04161323CID003640214
DrugYF-1

NLRP7 NLRP2 PHEX NOD1 RALBP1

1.23e-04831325CID000445779
DrugAM-m

GPAM ACE MMEL1 AGT

1.34e-04451324CID005494407
Drugdihydropyridine

CACNA1C ACE IGHMBP2 AGT PRKACA PRKACB CACNA1G

1.36e-041931327CID000104822
DrugCloperastine hydrochloride [14984-68-0]; Up 200; 11uM; MCF7; HT_HG-U133A

IL12RB2 RAPGEF5 GPR87 GREB1L CD1E MID1 PRKACA

1.36e-0419313273608_UP
DrugAC1L2V0Q

ACE BDKRB1 AGT

1.46e-04181323CID000129109
DrugHarmalol hydrochloride dihydrate [6028-07-5]; Up 200; 14.6uM; PC3; HT_HG-U133A

SEMA3F ITGA8 TBC1D8B STAT2 MTMR3 SLC9A7 CACNA1G

1.55e-0419713275076_UP
Drugthiorphan

ACE BDKRB1 MMEL1 AGT TACR3

1.62e-04881325CID000003132
DrugAmiloride hydrochloride dihydrate [17440-83-4]; Up 200; 13.2uM; HL60; HG-U133A

TRPM2 ST3GAL1 SBNO2 VPS13A PRKACB MTMR3 FMNL1

1.64e-0419913271970_UP
DrugAC1L8Y60

ACE SLC12A2 AGT MID1 SLC9A7

1.71e-04891325CID000410009
DrugAC1MVZ0B

ACE BDKRB1 MMEL1 AGT

1.72e-04481324CID003691183
DrugVanlev

ACE BDKRB1 MMEL1 AGT

1.72e-04481324CID000126046
DrugNSC612475

ACE AGT

1.99e-0441322CID000003412
DrugL-158,338

ACE AGT

1.99e-0441322CID003036053
DrugAC1L9QEO

ACE AGT

1.99e-0441322CID000452589
DrugMoveltipril [INN]

ACE AGT

1.99e-0441322CID005745793
DrugAC1L1HJI

ACE AGT

1.99e-0441322CID000054684
Drugglycopril

ACE AGT

1.99e-0441322CID000131848
DrugGR138950

ACE AGT

1.99e-0441322CID000060921
Drugalpha-Lactorphin

ACE AGT

1.99e-0441322CID000128807
DrugUtibaprilo

ACE AGT

1.99e-0441322CID000060359
DrugRac X 65

ACE AGT

1.99e-0441322CID005748390
DrugH 142

ACE AGT

1.99e-0441322CID000134897
DrugHippuryl-phe-arg

ACE AGT

1.99e-0441322CID000194496
Drugomapatrilat

ACE MMEL1

1.99e-0441322ctd:C106266
DrugBILA 2157 BS

ACE AGT

1.99e-0441322CID000157824
DrugSQ 28,603

ACE MMEL1 AGT

2.02e-04201323CID000123742
Drugcandoxatrilat

ACE MMEL1 AGT

2.02e-04201323CID000123697
Drugazelnidipine

CACNA1C ACE AGT DYNC1H1

2.18e-04511324CID000065948
Drugkallidin1-9

ACE BDKRB1 AGT

2.35e-04211323CID000122227
DrugAC1L9JWW

ACE DYNC1H1 DNAH11

2.35e-04211323CID000446637
DrugBradykinin[1-8]

ACE BDKRB1 AGT

2.35e-04211323CID000105044
DrugIC261

NLRP7 NLRP2 BDKRB1 DYNC1H1 DNAH11

2.43e-04961325CID000003674
Drugmyo-inositol

CACNA1C GPR87 NT5C3B INPP5F BDKRB1 PTH2R PGAP2 AGT PRKACA PRKACB MTMR3 CACNA1G TACR3 PLCG1

2.66e-0481113214CID000000892
DrugDOCP

SLC12A2 AGT VPS13A

2.71e-04221323CID000013126
Drugcilazaprilat

ACE BDKRB1 AGT

3.10e-04231323CID000064766
DrugEnalaprilat

ACE BDKRB1 AGT

3.10e-04231323ctd:D015773
DrugCinildipine

CACNA1C ACE AGT CACNA1G

3.14e-04561324CID000002752
DrugSpiraprilate

ACE AGT

3.30e-0451322CID000134290
DrugBMS-189921

ACE AGT

3.30e-0451322CID000172318
DrugAC1L1DX8

ACE AGT

3.30e-0451322CID000002546
DrugAaphgpspla

BDKRB1 AGT

3.30e-0451322CID003083242
DrugFK 739

ACE AGT

3.30e-0451322CID000131933
DrugBW A575C

ACE AGT

3.30e-0451322CID000128240
DrugAce inhibitor BG-2

ACE AGT

3.30e-0451322CID000115370
DrugEXP132

ACE AGT

3.30e-0451322CID000132313
DrugAC1L1SQ2

ACE AGT

3.30e-0451322CID000060183
DrugEnalkiren

ACE AGT

3.30e-0451322CID000060594
DrugCGP 48369

ACE AGT

3.30e-0451322CID000192267
Drugphosphorothioate

IL12RB2 PMS2 GPR87 NOD1 RALBP1 TLR3 PRKACA PRKACB

3.40e-042961328CID000167253
DiseaseParkinson's disease 23 (implicated_via_orthology)

VPS13C VPS13A

1.87e-0521282DOID:0060896 (implicated_via_orthology)
Diseasechoreaacanthocytosis (implicated_via_orthology)

VPS13C VPS13A

1.87e-0521282DOID:0050766 (implicated_via_orthology)
Diseaseautosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology)

VPS13C VPS13A

5.59e-0531282DOID:0111611 (implicated_via_orthology)
DiseaseCohen syndrome (implicated_via_orthology)

VPS13C VPS13A

5.59e-0531282DOID:0111590 (implicated_via_orthology)
DiseaseWeight Gain

ZWILCH ACE IPO11 DNAH11 LARGE1

8.45e-051021285C0043094
DiseaseRenal Tubular Dysgenesis With Choanal Atresia And Athelia

ACE AGT

1.11e-0441282C2678367
DiseaseRenal tubular dysgenesis of genetic origin

ACE AGT

1.11e-0441282cv:C5681536
DiseaseRENAL TUBULAR DYSGENESIS

ACE AGT

1.11e-0441282267430
Diseasefamilial adenomatous polyposis (is_marker_for)

AXIN2 PLCG1

1.11e-0441282DOID:0050424 (is_marker_for)
DiseaseAllanson Pantzar McLeod syndrome

ACE AGT

1.11e-0441282C0266313
Diseaserenal agenesis (is_implicated_in)

ITGA8 GREB1L

1.11e-0441282DOID:14766 (is_implicated_in)
DiseaseRenal tubular dysgenesis

ACE AGT

1.11e-0441282cv:C0266313
DiseaseTesticular Diseases

TSC22D3 IGSF1

1.11e-0441282C0039584
DiseaseCoronary heart disease

ACE MIR17HG DNAH11

1.51e-04241283C0010068
DiseaseCardiac Arrhythmia

CACNA1C ACE AGT

1.71e-04251283C0003811
DiseaseFabry disease (is_implicated_in)

ACE AGT

1.85e-0451282DOID:14499 (is_implicated_in)
DiseaseCongenital absence of kidneys syndrome

ITGA8 GREB1L

1.85e-0451282C1609433
DiseaseSudden death

ACE AGT

1.85e-0451282C0011071
DiseaseBipolar Disorder

CACNA1C RAPGEF5 FSTL5 TRPM2 ST3GAL1 ACE STAB1 AGT PLCG1

2.44e-044771289C0005586
Diseasehypertension (implicated_via_orthology)

ACE BDKRB1 SLC12A2 AGT TACR3

2.45e-041281285DOID:10763 (implicated_via_orthology)
Diseasebipolar disorder, autism spectrum disorder

CACNA1C FSTL5

2.77e-0461282EFO_0003756, MONDO_0004985
DiseaseManic

CACNA1C FSTL5 TRPM2 STAB1

3.76e-04781284C0338831
DiseaseCardiovascular Diseases

ACE SLC12A2 AGT

5.13e-04361283C0007222
Diseasecerebellar ataxia (implicated_via_orthology)

VPS13C VPS13A

5.14e-0481282DOID:0050753 (implicated_via_orthology)
DiseaseHenoch-Schoenlein purpura (is_implicated_in)

ACE AGT

5.14e-0481282DOID:11123 (is_implicated_in)
Diseasetransient cerebral ischemia (biomarker_via_orthology)

TRPM2 AXIN2 PPP2R5E SLC12A2 AGT

6.25e-041571285DOID:224 (biomarker_via_orthology)
Diseasemitral valve prolapse (is_implicated_in)

ACE AGT

6.59e-0491282DOID:988 (is_implicated_in)
Diseaseend stage renal disease (is_implicated_in)

ITGA8 ACE BDKRB1

7.53e-04411283DOID:783 (is_implicated_in)
DiseaseIntellectual Disability

LINS1 FRY MIR17HG PGAP2 SNX27 CACNA1G DYNC1H1 LARGE1

7.65e-044471288C3714756
DiseasePsychotic Disorders

CACNA1C TRPM2 ST3GAL1 SLC12A2

9.97e-041011284C0033975
DiseaseColorectal Carcinoma

NPBWR2 PMS2 FSTL5 CD109 GPR87 CHD1 CSMD3 ABCA9 AXIN2 VPS13A

9.98e-0470212810C0009402
Diseaseinterleukin-6 measurement, response to stimulus

ELAPOR2 FSTL5

1.00e-03111282EFO_0004810, GO_0050896
Diseasepulmonary fibrosis (implicated_via_orthology)

ACE AGT

1.20e-03121282DOID:3770 (implicated_via_orthology)
DiseaseStreptozotocin Diabetes

GPAM ACE BDKRB1 AGT

1.28e-031081284C0038433
DiseaseDiabetes Mellitus, Experimental

GPAM ACE BDKRB1 AGT

1.28e-031081284C0011853
DiseaseAlloxan Diabetes

GPAM ACE BDKRB1 AGT

1.28e-031081284C0002152
DiseaseIGF-1 measurement

DENND5B OR5T1 OR5T3 LMF1 OSTM1 VPS13C ST3GAL1 DDX60L

1.34e-034881288EFO_0004627
Diseasecolon carcinoma (is_marker_for)

AXIN2 TLR3

1.41e-03131282DOID:1520 (is_marker_for)
Diseaseintermediate coronary syndrome (is_marker_for)

ACE AGT

1.41e-03131282DOID:8805 (is_marker_for)
DiseaseHypertensive disease

CACNA1C ACE SLC12A2 RALBP1 AGT

1.47e-031901285C0020538
Diseaseatrial fibrillation (is_implicated_in)

ACE AGT

1.64e-03141282DOID:0060224 (is_implicated_in)
Diseasefacial morphology

ITGA8 GPAM TAS1R2

1.77e-03551283EFO_0004743
Diseaseallergic disease (is_implicated_in)

ACE AGT

1.89e-03151282DOID:1205 (is_implicated_in)
DiseasePre-Eclampsia

ACE AGT

2.15e-03161282C0032914
DiseaseRenal Insufficiency

ACE AGT

2.43e-03171282C1565489
DiseaseLimb Deformities, Congenital

CACNA1C MIR17HG

2.43e-03171282C0206762
DiseaseCharcot-Marie-Tooth disease type 2

IGHMBP2 DYNC1H1

2.43e-03171282cv:C0270914
Diseaseperinatal necrotizing enterocolitis (biomarker_via_orthology)

TLR6 TLR3

2.43e-03171282DOID:8677 (biomarker_via_orthology)
DiseaseProfound Mental Retardation

LINS1 FRY CACNA1G DYNC1H1

3.20e-031391284C0020796
DiseaseMental Retardation, Psychosocial

LINS1 FRY CACNA1G DYNC1H1

3.20e-031391284C0025363
DiseaseMental deficiency

LINS1 FRY CACNA1G DYNC1H1

3.20e-031391284C0917816
DiseaseNonorganic psychosis

CACNA1C TRPM2 ST3GAL1

3.39e-03691283C0349204
DiseaseManic Disorder

CACNA1C FSTL5 TRPM2

3.68e-03711283C0024713
DiseaseLeft Ventricle Remodeling

AXIN2 AGT

3.71e-03211282C0600520
DiseaseVentricular Remodeling

AXIN2 AGT

3.71e-03211282C0600519
Diseasedilated cardiomyopathy (biomarker_via_orthology)

AXIN2 AGT

4.07e-03221282DOID:12930 (biomarker_via_orthology)
DiseaseKidney Failure

ACE AGT

4.07e-03221282C0035078

Protein segments in the cluster

PeptideGeneStartEntry
INNIFLRFVYETEHF

PPP2R5E

221

Q16537
FRVFESFYEHVNQKL

ERV3-1

251

Q14264
FFNTLYHNNIPLFIF

NT5C3B

141

Q969T7
AAIVFFNYHILASLR

BDKRB1

216

P46663
LQFVNFSTETIHDYL

CSMD3

2151

Q7Z407
IRYFVSFIIQFQFHE

ACE

1126

P12821
VLFLYLFFSNLHQVH

ABCA9

41

Q8IUA7
TVNTLLFFHLILSYF

GPR33

61

Q49SQ1
LDALNTIYGQIFSFH

DNAH11

2651

Q96DT5
VHALQASELVVTYFF

AXIN2

756

Q9Y2T1
LNLYEQFHRVSNLFF

ATP8B3

151

O60423
NRDALSFHYLFAIFS

CELSR1

2676

Q9NYQ6
TLQFFTHFSSLIYIA

ANO9

426

A1A5B4
TISFLNYLFHEHQLY

CHD1

516

O14646
FLFAVYDQSATALHF

AGT

451

P01019
SALEIFHVDQSNYFL

NBEAL1

1951

Q6ZS30
VLYVFFTHVQELFGN

RALBP1

356

Q15311
SDVAQYINFHFSLLE

RASSF6

311

Q6ZTQ3
YVYSHFLQFALAATV

LBR

321

Q14739
LHTYSLSANDFFNIE

PCDH18

171

Q9HCL0
TFFHNYNILIATLRV

MCOLN1

406

Q9GZU1
NTLYVHFILFAREFN

MOB2

176

Q70IA6
QHFLDSYQVMFFTLF

NUP210

1801

Q8TEM1
FISFFSALAVYFRHN

PGAP2

191

Q9UHJ9
SGSINAFIHTLYVFQ

OR2AK2

166

Q8NG84
FYAAQIVLTFEYLHS

PRKACA

146

P17612
NKHVEFFRNLYLTFL

LARGE1

391

O95461
DTIFEVFYNSLFSQH

LINS1

221

Q8NG48
VFGLRSHVANNIFYF

CFAP57

11

Q96MR6
FYSVLLNIFTNHTLD

IPO11

41

Q9UI26
VLFIDIFHEYNQTLT

IPO11

411

Q9UI26
FSTHYFQQKVFVLLA

IL12RB2

641

Q99665
LVLIYLQSHFVLFFF

MIR17HG

26

Q75NE6
SDLQTYLFNFLIIHS

DDX60L

151

Q5H9U9
INLSFTVIFFHFDYK

PCNX2

1246

A6NKB5
AHICVFLQFYLLAFF

OR52A1

246

Q9UKL2
AHICVFLQFYLLAFF

OR52A5

246

Q9H2C5
YFNKFQSHIIIRFDL

OLFM1

311

Q99784
TVIDYFHQLLQTFNF

DDIAS

176

Q8IXT1
AQHLTYLEFRSFQAI

RASGRP4

206

Q8TDF6
QSYEFFHLTLQAFFT

NOD1

511

Q9Y239
FIHLSFQQFLTALFY

NLRP2

501

Q9NX02
LAFELYYHTTQDLQL

PGGHG

376

Q32M88
ELSNSTVYFLNLFNH

OSTM1

181

Q86WC4
TVYFLNLFNHTLTCF

OSTM1

186

Q86WC4
GLDLTHEQLFFINYA

MMEL1

706

Q495T6
FRYFTEFSNHINLKL

GREB1L

191

Q9C091
QFATALFSFLYHLAS

HUWE1

381

Q7Z6Z7
LAVDHYNIFSSIYFL

NPBWR2

121

P48146
QAYTHIIFKNATFTF

ELAPOR2

551

A8MWY0
IFFHIRNKTSFIFYL

GPR87

66

Q9BY21
FSARDEFLLYIFHIQ

ITGA8

846

P53708
HQLFHIFTFLSIYDQ

PAQR9

311

Q6ZVX9
FDIYTNLHISDLAFQ

FSTL5

731

Q8N475
QYSNLLKIHFTFTQF

ITGAD

191

Q13349
TDSRFQTLTYFFLQH

OR5AK2

51

Q8NH90
QTLTYFFLQHLAFVD

OR5AK2

56

Q8NH90
CSDTHVIQLLFFYFV

OR5T1

201

Q8NG75
LFQLYFHSFIQIVQA

CD1E

96

P15812
AYALLSHFLQFQTSE

CD109

1146

Q6YHK3
LLFSLYSEFKNSQHF

IFT46

261

Q9NQC8
FFFQSLKIQDTGHYL

IGSF1

281

Q8N6C5
FYAAQIVLTFEYLHS

PRKACB

146

P22694
TSFRNHILFYFDIVF

CACNA1C

926

Q13936
AHSFYNFIYFILLII

CACNA1G

366

O43497
LNNHIFLFTRDFSRY

CCDC175

596

P0C221
VYFHNLSQKVFGTLF

FITM2

211

Q8N6M3
NQFFAALLTAVLTYH

FNIP2

431

Q9P278
QFLYHLLSLNAVDYF

DENND5B

911

Q6ZUT9
LYAALSYNLHVLDFQ

FBXW4

396

P57775
NFRVFLQYEFTHLGL

FMNL1

341

O95466
IHFLYQYSLQFFLDI

DYNC1H1

3821

Q14204
QYSLQFFLDIYHNVL

DYNC1H1

3826

Q14204
RDAFHIISYFLFQVL

HAUS6

51

Q7Z4H7
VYTFHVFSSLFKNIQ

FRY

2701

Q5TBA9
ESNNTFLLHFILDFY

CENPI

551

Q92674
LLFNNSHLTYVSFDF

INPP5F

396

Q9Y2H2
FNEAFLVKLVQHTYS

MTMR3

496

Q13615
DTHTNQLLLFYFVGS

OR5T3

221

Q8NGG3
VLQVLTNIFLYHDFS

ORC3

306

Q9UBD5
TNIFLYHDFSVQNFI

ORC3

311

Q9UBD5
QYHFVFNNFFTSIAL

PGBD3

346

Q8N328
LTQMFFLHYNFVLDS

OR52H1

106

Q8NGJ2
FEFYITLIQSHQAFA

CFAP221

191

Q4G0U5
YLLKIANFSNFIFLH

TAS2R43

106

P59537
ATMLFFHFLDQLNYE

STAT2

56

P52630
VFFSFFIVTLLCHYN

SLC35F5

461

Q8WV83
HFFNFLLNTTDYRIL

SEMA3F

46

Q13275
NAFVFNFLLYPSAHV

TMEM229A

116

B2RXF0
EVAVYQLHNFSISFF

TSC22D3

11

Q99576
DLAHVFYLSYFSINA

TMEM191A

121

Q9H0A3
HISFALYVDNRFFTL

NBPF20

5176

P0DPF2
HISFALYVDNRFFTL

NBPF26

871

B4DH59
LSAYAANVHYLFITF

SLC16A14

116

Q7RTX9
SFFNVDLSQHLYTFS

FSD2

701

A1L4K1
VFELNFYSNGVLHVF

GPAM

566

Q9HCL2
SLLFHSINYYFINSQ

GPR108

306

Q9NPR9
FNSIHEQELIYFTFS

RAPGEF5

361

Q92565
VLFIFLTSFFLNYSH

ST3GAL1

16

Q11201
FFFVYICQFAVHVLQ

SCAMP1

221

O15126
NALFQYFSDTFDHLI

SBNO2

981

Q9Y2G9
FIHLSFQQFLTALFY

NLRP7

466

Q8WX94
HLYNFHVVQSLLIFD

NOM1

471

Q5C9Z4
LSQYHRQTEVFTLFF

ARHGAP5

921

Q13017
FSAIIYFFIRTLQAH

IMPG2

1116

Q9BZV3
AFNTLVNFIYALHSE

TACR3

136

P29371
THTNQLLLFYFVGSI

OR5T2

231

Q8NGG2
YAQRASVAFHTQLFF

DIS3

826

Q9Y2L1
NIFLRFIYETEHFNG

PPP2R5A

231

Q15172
FIGQELASLNHLEYF

ZWILCH

436

Q9H900
EYFFLEYNNIQHLFS

TLR3

301

O15455
VVFKLAFFELNYQFH

VPS13A

2821

Q96RL7
AFFELNYQFHTTSDL

VPS13A

2826

Q96RL7
QFIQFSKTLYNLFHE

TBC1D8B

991

Q0IIM8
FIADSHQNFALFFQL

RPN2

406

P04844
TVNNHAFLKTLVEYF

IGHMBP2

616

P38935
VVVFHLNILSYFAFL

TRPM2

796

O94759
FQHLLEFLYTSEFFV

ZBTB41

136

Q5SVQ8
FFLASYALINFSVFH

SLC12A2

681

P55011
LNSIHLYTFDVAFAQ

MID1

621

O15344
HIFNNYRNDFLFSTL

ZNF534

171

Q76KX8
ITFTNNQLFFLSYAH

PHEX

676

P78562
NLVFDSLYDLITHYQ

PLCG1

626

P19174
NYFALFEVISHSFVR

SNX27

316

Q96L92
IFRELEANAHFSIFY

STAB1

991

Q9NY15
LQFDFHFESLSIILY

VPS13C

1936

Q709C8
LVFQLTIHFTSEYNY

UBE2U

51

Q5VVX9
DFYTSHNLVKNLALF

PKHD1L1

3951

Q86WI1
LHNLIFVAFFSDTKY

PTH2R

261

P49190
LYHFFNEVLRQNFTG

TAS1R2

281

Q8TE23
HITNQVFLFSQTALY

TLR6

311

Q9Y2C9
DALHNLFYISGFISQ

PMS2

261

P54278
FLDSSTLQLFFDLYH

XPO7

256

Q9UIA9
ANTFLLLFHIFTFAY

VN1R17P

26

Q8TDU5
QLFEVLHFLAENFIF

SLC9A7

411

Q96T83
FFNVTNHGALIYKFS

TRIM22

456

Q8IYM9
AFVYFVAFLVAFHQN

LMF1

61

Q96S06
FFNLSVLYLHGNSIQ

LRRC51

101

Q96E66
NAFTGLSHLQYLFIE

LGI3

106

Q8N145
YTSILHLFNVNFTDE

LRIG2

561

O94898